218627-10-2

Basic information

• Product Name: 3-[5-[3-[3-[(aminoiminomethyl)amino]phenyl]-1-oxopropenyl]-2-fluorophenyl]propenoic acid, trifluoroacetate salt
• Synonyms: 3-[5-[3-[3-[(aminoiminomethyl)amino]phenyl]-1-oxopropenyl]-2-fluorophenyl]propenoic acid, trifluoroacetate salt
• CAS NO: 218627-10-2
• Molecular Weight: 467.377
• Mol File: 218627-10-2.mol

Chemical Properties

• CAS DataBase Reference: 3-[5-[3-[3-[(aminoiminomethyl)amino]phenyl]-1-oxopropenyl]-2-fluorophenyl]propenoic acid, trifluoroacetate salt(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[5-[3-[3-[(aminoiminomethyl)amino]phenyl]-1-oxopropenyl]-2-fluorophenyl]propenoic acid, trifluoroacetate salt(218627-10-2)
• EPA Substance Registry System: 3-[5-[3-[3-[(aminoiminomethyl)amino]phenyl]-1-oxopropenyl]-2-fluorophenyl]propenoic acid, trifluoroacetate salt(218627-10-2)

Safety Data

• Hazardous Substances Data: 218627-10-2(Hazardous Substances Data)

Upstream product

• 1007-15-4 4-fluoro-3-bromoacetophenone 
• 99-61-6 3-nitro-benzaldehyde 

Relevant articles and documents

CINNAMIC ACID DERIVATIVES AND THEIR USE AS INTEGRIN ANTAGONISTS

The present invention relates to a class of compounds represented by the Formula I or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the alpha v beta 3 integrin.

Cinnamic acid derivatives

The present invention relates to a class of compounds represented by the Formula I STR1 or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the αv β3 integrin.